Professor Perminder Sachdev

A dietary supplement may represent a novel strategy for the treatment and/or prevention of cognitive impairment and Alzheimer’s disease.

People with enlarged fluid-filled spaces in the brain around small blood vessels may be more likely to develop dementia than people whose perivascular spaces are smaller, according to a new study led by CHeBA.

Software developed by CHeBA researchers has enabled an investigation into the relationship between sex differences and cerebral small vessel disease.

Research shows cognitive decline may be increased with use of antihypertensive medications.

A six-year study of older Australians with type 2 diabetes has uncovered a link between metformin use, slower cognitive decline and lower dementia rates.

September 21st is World Alzheimer's Day.